Department of Microbiology and Immunology, Drexel University College of Medicine, Philadelphia, PA, USA.
Antimicrob Agents Chemother. 2012 Dec;56(12):6304-9. doi: 10.1128/AAC.00813-12. Epub 2012 Oct 1.
The echinocandins caspofungin, micafungin, and anidulafungin, inhibitors of cell wall β-1,3-glucan synthesis, were recently elevated to first-line agents for treating infections due to the azole-refractory yeast Candida glabrata. In Candida albicans, echinocandin resistance is strictly associated with mutations in Fks1, a large integral membrane protein and putative β-1,3-glucan synthase, while mutations in both Fks1 and its paralog Fks2 (but not Fks3) have been associated with resistance in C. glabrata. To further explore their function, regulation, and role in resistance, C. glabrata fks genes were disrupted and subjected to mutational analysis, and their differential regulation was explored. An fks1Δ fks2Δ double disruptant was not able to be generated; otherwise, all three single and remaining two double disruptants displayed normal growth and echinocandin susceptibility, indicating Fks1-Fks2 redundancy. Selection on echinocandin-containing medium for resistant mutants was dependent on strain background: only fks1Δ and fks1Δ fks3Δ strains consistently yielded mutants exhibiting high-level resistance, all with Fks2 hot spot 1 mutations. Thus, Fks1-Fks2 redundancy attenuates the rate of resistance; further analysis showed that it also attenuates the impact of resistance-conferring mutations. Growth of the fks1Δ and, especially, fks1Δ fks3Δ strains was specifically susceptible to the calcineurin inhibitor FK506. Relatedly, FK506 addition or calcineurin gene CMP2 disruption specifically reversed Fks2-mediated resistance of laboratory mutants and clinical isolates. RNA analysis suggests that transcriptional control is not the sole mechanism by which calcineurin modulates Fks2 activity.
棘白菌素类药物卡泊芬净、米卡芬净和阿尼芬净是细胞壁β-1,3-葡聚糖合成的抑制剂,最近被提升为治疗唑类耐药酵母假丝酵母菌感染的一线药物。在白色念珠菌中,棘白菌素耐药性与 Fks1 基因突变严格相关,Fks1 是一种大型整合膜蛋白和假定的β-1,3-葡聚糖合酶,而 C. glabrata 中的 Fks1 和其同源物 Fks2(而非 Fks3)的突变与耐药性相关。为了进一步探索它们的功能、调节和在耐药性中的作用,我们敲除了 C. glabrata 的 fks 基因并进行了突变分析,并探索了它们的差异调节。不能产生 fks1Δ fks2Δ 双缺失突变体;否则,所有三种单缺失和两种剩余双缺失突变体均显示正常生长和棘白菌素敏感性,表明 Fks1-Fks2 冗余。在含棘白菌素的培养基上进行耐药突变体的选择取决于菌株背景:只有 fks1Δ 和 fks1Δ fks3Δ 菌株一致产生表现出高水平耐药性的突变体,所有突变体均具有 Fks2 热点 1 突变。因此,Fks1-Fks2 冗余会降低耐药性的发生速度;进一步的分析表明,它也会降低耐药性赋予突变的影响。fks1Δ 和特别是 fks1Δ fks3Δ 菌株的生长特别容易受到钙调神经磷酸酶抑制剂 FK506 的影响。相关地,FK506 的添加或钙调神经磷酸酶基因 CMP2 的缺失特异性地逆转了实验室突变体和临床分离株中 Fks2 介导的耐药性。RNA 分析表明,转录控制不是钙调神经磷酸酶调节 Fks2 活性的唯一机制。